human
metapneumoviru
hmpv
crucial
pathogen
children
cell
entri
first
step
infect
previou
studi
indic
endocytosi
pathway
hmpv
cell
entri
lipid
raft
specif
structur
cell
surfac
demonstr
play
import
role
endocytosi
process
mani
virus
studi
investig
whether
lipid
raft
take
part
hmpv
entri
confoc
microscop
use
detect
coloc
hmpv
lipid
raft
marker
demonstr
coloc
increas
along
viral
infect
hmpv
particl
transfer
perinuclear
region
lipid
raft
specif
lipid
raft
inhibitor
cyclodextrin
nystatin
use
hmpv
cell
entri
inhibit
viral
titer
decreas
dramat
replenish
exogen
cholesterol
hmpv
recov
quickli
data
suggest
lipid
raft
play
import
role
hmpv
endocytosi
mayb
one
pathway
hmpv
cell
entri
k
e
w
r
cell
entri
human
metapneumoviru
lipid
raft
introduct
human
metapneumoviru
hmpv
firstli
isol
airway
secret
identifi
base
viral
gene
sequenc
analysi
hmpv
belong
metapneumoviru
genu
paramyxovirida
famili
pneumovirina
subfamili
global
epidemiolog
survey
show
hmpv
preval
worldwid
sever
bronchiol
pneumonia
morbid
hmpv
infect
vari
predomin
strain
subtyp
suscept
popul
hmpv
infant
young
children
immunocompromis
individu
elderli
peopl
children
year
old
almost
infect
hmpv
recent
respiratori
problem
caus
hmpv
becam
obviou
neglect
anymor
hmpv
could
caus
lethal
infect
posttranspl
patient
bring
seriou
consequ
host
coinfect
viru
howev
date
effect
vaccin
prevent
hmpv
infect
two
main
pathway
viru
cell
entri
fuse
cellular
membran
fusion
endocytosi
endocytosi
complex
process
procedur
viru
bind
specif
receptor
cell
membran
firstli
downstream
signal
j
med
virol
wileyonlinelibrarycomjournaljmv
cascad
activ
endocyt
intern
promot
final
viru
particl
could
endocytos
intact
form
transport
specif
organel
vesicl
accord
differ
vector
main
four
kind
endocyt
pathway
defin
clathrin
caveola
cholesterolmedi
endocytosi
macropinocytosi
recent
hmpv
found
invad
cell
via
endocytosi
previou
studi
also
found
hmpv
use
endocytosi
pathway
vero
cell
line
cell
membran
first
barrier
prevent
invad
accord
classic
liquid
mosaic
model
theori
cell
membran
homogen
lipid
bilay
embed
differ
protein
lipid
raft
play
critic
role
signal
transduct
protein
traffick
also
import
establish
cell
polar
besid
lipid
raft
crucial
impact
viral
entri
process
mani
virus
found
lipid
raft
particip
earli
infect
viru
also
bind
process
hepat
c
viru
key
element
human
immunodefici
viral
entri
also
gateway
ebola
viru
bud
studi
found
morpholog
evid
hmpv
coloc
lipid
raft
enter
target
cell
via
lipid
raft
lipid
raft
inhibitor
use
hmpv
cell
entri
inhibit
besid
cultur
medium
contain
fetal
bovin
serum
gibco
penicillinstreptomycin
antibiot
hyclon
lo
angel
ca
hmpv
use
studi
belong
genotyp
hmpv
cell
use
viru
propag
viru
particl
releas
medium
freezethaw
centrifug
remov
cell
debri
supernat
store
detect
whether
two
chemic
agent
affect
cell
viabil
cell
seed
densiti
ml
corn
ny
plate
cell
incub
hour
treat
differ
concentr
nystatin
cell
count
dojindo
kumamoto
japan
solut
ad
medium
incub
minut
incub
fluoresc
absorb
nm
detect
micropl
reader
formula
fluoresc
absorb
use
calcul
cell
viabil
without
drug
free
cholesterol
assay
kit
applygen
technolog
beij
china
use
quantifi
cellular
cholesterol
concentr
treat
mgml
accord
experiment
manual
cholesterol
concentr
calcul
standard
curv
cell
seed
densiti
ml
glass
bottom
cell
cultur
dish
nest
hangzhou
china
wash
phosphatebuff
salin
pb
three
time
incub
hour
alexa
ctb
life
technolog
carlsbad
ca
purifi
hmpv
moi
inocul
experiment
group
time
cell
place
hour
ctb
hmpv
attach
cell
surfac
could
initi
endocytosi
cell
transfer
minut
initi
endocytosi
ctb
hmpv
last
immunofluoresc
analysi
wash
pb
three
time
cell
seed
plate
corn
cell
densiti
ml
wash
serumfre
dmem
three
time
treat
mgml
sigma
munich
germani
nystatin
sigma
hour
two
pharmacolog
agent
dilut
serumfre
dmem
cholesterol
replenish
experi
cell
treat
mgml
hour
watersolubl
cholesterol
sigma
ad
cultur
system
hour
final
concentr
cholesterol
oper
mention
complet
cell
inocul
amount
hmpv
moi
step
cell
wash
serumfre
dmem
three
time
remov
residu
drug
unbound
viru
viru
titer
detect
quantit
polymeras
chain
reaction
qpcr
hour
postinfect
ctb
control
intern
cell
treat
mgml
hour
wash
pb
three
time
final
concentr
ctb
hour
wash
pb
three
time
cell
fix
paraformaldehyd
control
group
treat
cell
cultur
glass
bottom
dish
wash
pb
three
time
cell
treat
mgml
nystatin
hour
inocul
amount
hmpv
moi
wash
pb
three
time
cell
place
hour
hmpv
attach
cell
surfac
could
initi
endocytosi
cell
transfer
minut
initi
endocytosi
immunofluoresc
analysi
wash
pb
three
time
result
percentag
experiment
group
control
group
data
analyz
oneway
analysi
varianc
use
graphpad
prism
version
graphpad
softwar
la
jolla
ca
use
repres
p
valu
p
p
p
determin
whether
lipid
raft
particip
process
hmpv
cell
entri
morpholog
analysi
use
ctb
subunit
lipid
raftdepend
intern
marker
bind
receptor
gangliosid
enter
cell
lipid
raft
shown
result
coloc
ctb
hmpv
found
cell
number
coloc
ctb
hmpv
increas
cell
time
increas
figur
analysi
show
f
g
u
r
e
hmpv
coloc
lipid
raft
marker
cell
infect
purifi
hmpv
moi
alexa
ctb
ad
time
ctb
green
purifi
hmpv
red
coloc
cell
number
coloc
point
yellow
analyz
ni
element
ar
softwar
b
posit
coloc
point
mark
white
arrow
number
coloc
point
near
nucleu
analyz
ctb
cholera
toxin
b
hmpv
human
metapneumoviru
coloc
point
appear
surfac
cell
membran
minut
appear
cytoplasm
around
nucleu
minut
facilit
analysi
cytoplasm
divid
two
part
one
part
onethird
cytoplasm
close
cell
membran
anoth
twothird
cytoplasm
near
nucleu
number
coloc
point
around
nucleu
increas
time
figur
result
indic
hmpv
coloc
gradual
toward
nucleu
lipid
raft
use
remov
cholesterol
surfac
cell
membran
deriv
cyclic
oligosaccharid
rapidli
remov
cholesterol
surfac
cell
membran
result
disrupt
lipid
raft
pretreat
watersolubl
cholesterol
ad
cultur
system
exogen
cholesterol
ad
cultur
system
treat
viru
titer
increas
trend
exogen
cholesterol
concentr
decreas
hmpv
titer
caus
recov
figur
figur
compar
untreat
cell
hmpv
titer
decreas
respect
p
nystatin
toxic
effect
concentr
figur
result
show
cholesterol
chelat
agent
could
reduc
hmpv
titer
caus
drug
toxic
found
number
fluoresc
point
drug
treatment
group
decreas
dramat
p
figur
ctb
often
use
intern
coloc
assay
recommend
found
ctb
green
fluoresc
treatment
group
decreas
obvious
compar
treatment
confoc
microscopi
cell
without
show
green
fluoresc
masslik
distribut
treatment
cell
obviou
scatter
figur
fluoresc
intens
ctb
treatment
decreas
significantli
p
figur
previou
studi
show
hmpv
exist
whole
particl
cytoplasm
membran
fusion
occur
cytoplasm
taken
togeth
data
indic
hmpv
may
enter
host
cell
via
endocytosi
exist
mani
way
endocyt
pathway
clathrin
caveola
cholesterolmedi
endocytosi
macropinocytosi
lipid
cell
membran
form
special
lipid
structur
structur
enrich
sphingolipid
cholesterol
microdomain
usual
take
emigr
molecul
extracellular
microenviron
intracellular
region
name
lipid
raft
lipid
raft
play
critic
role
signal
transduct
protein
traffick
also
import
establish
cell
polar
studi
focus
effect
lipid
raft
viru
cell
entri
nystatin
antifung
medic
bond
cholesterol
well
also
use
studi
lipid
raft
treat
nystatin
hmpv
infect
rate
also
decreas
cell
concentr
nystatin
increas
viral
replic
f
g
u
r
e
nystatin
could
affect
hmpv
attach
treatment
nystatin
treatment
b
effect
hmpv
attach
hmpv
human
metapneumoviru
decreas
significantli
word
hmpv
infect
declin
lipid
raft
destroy
confirm
lipid
raft
play
import
role
hmpv
infect
shown
lipid
raft
particip
process
hmpv
infect
hmpv
could
reduc
treat
nystatin
howev
clear
whether
reduct
hmpv
titer
treat
chemic
inhibitor
associ
hmpv
cell
process
hmpv
cell
entri
treat
chemic
inhibitor
confirm
ifa
number
hmpv
enter
cell
reduc
significantli
result
consist
hmpv
titer
measur
hour
inhibitor
treatment
therefor
hmpv
first
bind
receptor
enter
host
cell
reduct
hmpv
attach
result
pharmacolog
agent
also
lead
decreas
hmpv
infect
hmpv
attach
treat
nystatin
detect
nystatin
effect
hmpv
attach
conclus
studi
show
lipid
raft
play
import
http
yao
zhao
http
